Search results for "dysbiosis"

showing 10 items of 107 documents

INTESTINAL DYSBIOSIS AND HORMONAL NEUROENDOCRINE SECRETION IN THE FIBROMYALGIC PATIENT: RELATIONSHIP AND CORRELATIONS

2018

Fibromyalgia is a rheumatic syndrome and its pathogenesis is controversial. The recent literature has placed considerable attention on the link between alteration of the intestinal microbiota and fibromyalgia, emphasizing the close connection between the neuroenteric system and the CNS. This study aims to evaluate the probable relationship between intestinal dysbiosis and altered secretion of hormones and vitamins such as cortisol, serotonin, Vitamin D and thyroid hormones in a patient with fibromyalgia.

Settore MED/18 - Chirurgia Generalemicrobiota fibromialgia hormones dysbiosis serotinin cortisol vitamin D
researchProduct

Effects of essential oils and selected compounds from Lamiaceae family as adjutants on the treatment of subjects with periodontitis and cardiovascula…

2021

Essential oils from different plant species were found to contain different compounds exhibiting anti-inflammatory effects with the potential to be a valid alternative to conventional chemotherapy that is limited in long-term use due to its serious side effects. Generally, the first mechanism by which an organism counteracts injurious stimuli is inflammation, which is considered a part of the innate immune system. Periodontitis is an infectious and inflammatory disease caused by a dysbiosis in the subgingival microbiome that triggers an exacerbated immune response of the host. The immune–inflammatory component leads to the destruction of gingival and alveolar bone tissue. The main anti-infl…

TechnologyQH301-705.5QC1-999VolatileInflammationDiseaseheart disease risk factorsoilvolatileProinflammatory cytokineImmune systemCarvacrolmedicineperiodontitiGeneral Materials ScienceMicrobiomeBiology (General)PeriodontitisperiodontitisQD1-999InstrumentationHeart disease risk factorsInflammationFluid Flow and Transfer ProcessesPeriodontitisEucalyptolInnate immune systembusiness.industrySettore BIO/16 - Anatomia UmanaTPhysicsProcess Chemistry and TechnologyGeneral EngineeringoilsEngineering (General). Civil engineering (General)medicine.diseaseComputer Science ApplicationsChemistryinflammationImmunologyRosmarinus officinalisTA1-2040medicine.symptombusinessOilsDysbiosis
researchProduct

IBD, malignancy and oral microbiota: Analysis of the literature

2016

The human microbiota, in adults, varies in number and species based on the location in the gastrointestinal tract. The highest concentration is at the intestinal level, where mainly Bacteroidetes, Actinobacteria, Firmicutes and proteobacteria are found. Instead, in the oral cavity, five major phyla exists. Firmicutes, Actinobacteria, Proteobacteria, Bacteroidetes and Fusobacteria. Variations in the microbiota cause bysbiosis, which is responsible to a great extent for the onset of many diseases including inflammatory bowel disease (IBD) and colorectal cancer (CRC). In some cases (8-10%) IBD has shown oral manifestations that may reflect a change in the composition of the oral microbiota. Th…

dysbiosis gut microbiota Inflammatory Bowel Diseases colorectal cancer CRC IBDSettore MED/12 - GastroenterologiaSettore MED/06 - Oncologia Medica
researchProduct

The influence of some dietary components on intestinal microbiota

2016

The gut microbiota is the set of symbiotic microorganisms that resides in our intestine. The interaction between the gut microbiota and the mucosal immune system can be altered as a result of shifts in the composition or metabolic activity of the intestinal microflora. Recent studies establish that diet is one of the main involved factors in determining the microbial composition of the gut suggesting its role as external factor able to promote the onset of specific diseases by disrupting the immune homeostasis. Starting from the evidence that the 57% of the gut microbiota’s entire variation are due to dietary alterations this review aims at providing an overview of the positive impact of so…

dysbiosis gut microbiota diet inflammatory bowel disease IBDSettore MED/18 - Chirurgia GeneraleSettore MED/12 - GastroenterologiaSettore MED/07 - Microbiologia E Microbiologia Clinica
researchProduct

The intestinal ecosystem and probiotics

2016

The term "probiotic" comes from the greek "pro bios" and means "pro life": Nowadays, an increasing number of pharmaceutical preparations and functional foods are enriched with probiotics and for the patients it is increasingly important to receive information needed to know how to orient in the choice. The benefits from probiotics are many and include the modulation of the intestinal microflora (stimulation of beneficial bacteria and inhibition of pathogens), the support of bowel function and the stimulation of the immune system. This broad spectrum of beneficial effects to maintain efficient the intestinal ecosystem. Therefore, probiotics are an useful tool to prevent the formation of diso…

dysbiosis intestinal microflora Inflammatory Bowel Disease IBD probiotics
researchProduct

Applying the Anna Karenina principle for wild animal gut microbiota : temporal stability of the bank vole gut microbiota in a disturbed environment

2020

Gut microbiota play an important role in host health. Yet, the drivers and patterns of microbiota imbalance (dysbiosis) in wild animals remain largely unexplored. One hypothesised outcome of stress on animal microbiomes is a destabilised microbial community that is characterised by an increase in inter-individual differences compared with microbiomes of healthy animals, which are expected to be (i) temporally stable and (ii) relatively similar among individuals. This set of predictions for response of microbiomes to stressors is known as the Anna Karenina principle (AKP) for animal microbiomes. We examine the AKP in a wild mammal inhabiting disturbed environments by conducting a capture-mar…

gut dysbiosisanthropogenic disturbancemetsämyyräAnna Karenina principlesuolistomikrobistoionisoiva säteilystable isotope analysisaltistuminenradiation exposureluonnonvaraiset eläimetChernobylenvironmental stresssäteilybiologia
researchProduct

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice

2018

The beneficial effects of probiotics on immune-based pathologies such as inflammatory bowel disease (IBD) have been well reported. However, their exact mechanisms have not been fully elucidated. Few studies have focused on the impact of probiotics on the composition of the colonic microbiota. The aim of the present study was to correlate the intestinal anti-inflammatory activity of the probiotic Escherichia coli Nissle 1917 (EcN) in the dextran sodium sulfate (DSS) model of mouse colitis with the changes induced in colonic microbiota populations. EcN prevented the DSSinduced colonic damage, as evidenced by lower disease activity index (DAI) values and colonic weight/length ratio, when compa…

intestinal microbiota0301 basic medicineDSS colitisIntestinal microbiotaProbioticmedicine.disease_causeInflammatory bowel diseaselaw.invention03 medical and health sciencesProbioticImmune systemlawmicroRNAmedicinePharmacology (medical)ColitisEscherichia coliOriginal ResearchPharmacologymicroRNAbusiness.industrylcsh:RM1-950PyrosequencingMicroRNAmedicine.diseasepyrosequencinglcsh:Therapeutics. Pharmacology030104 developmental biologyMechanism of actionImmunologymedicine.symptombusinessDysbiosisprobioticFrontiers in Pharmacology
researchProduct

Baseline Gut Microbiota Composition Is Associated With Schistosoma mansoni Infection Burden in Rodent Models

2020

In spite of growing evidence supporting the occurrence of complex interactions between Schistosoma and gut bacteria in mice and humans, no data is yet available on whether worm-mediated changes in microbiota composition are dependent on the baseline gut microbial profile of the vertebrate host. In addition, the impact of such changes on the susceptibility to, and pathophysiology of, schistosomiasis remains largely unexplored. In this study, mice colonized with gut microbial populations from a human donor (HMA mice), as well as microbiota-wild type (WT) animals, were infected with Schistosoma mansoni, and alterations of their gut microbial profiles at 50 days post-infection were compared to …

lcsh:Immunologic diseases. Allergy0301 basic medicineRodentImmunologyAntibodies ProtozoanSchistosomiasisGut floradigestive systemParasite LoadHost-Parasite InteractionsMicrobiologyImmunomodulationFecesMice03 medical and health sciences0302 clinical medicineimmune-modulationhuman-microbiota associated mouse modelsRNA Ribosomal 16Sbiology.animalLactobacillusmedicineAnimalsImmunology and AllergySchistosomaBacteriabiologyFOS: Clinical medicineComputational BiologyBiodiversitySchistosoma mansonidysbiosismedicine.diseasebiology.organism_classificationSchistosomiasis mansoniGastrointestinal MicrobiomeDisease Models Animal030104 developmental biologyhelminth-gut microbiota interactionsSchistosomaMetagenomicsSchistosoma mansonigut microbial diversityProteobacterialcsh:RC581-607Dysbiosis030215 immunology
researchProduct

Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice.

2020

Recent interest in the role of microbiota in health and disease has implicated gut microbiota dysbiosis in psychiatric disorders including major depressive disorder. Several antidepressant drugs that belong to the class of selective serotonin reuptake inhibitors have been found to display antimicrobial activities. In fact, one of the first antidepressants discovered serendipitously in the 1950s, the monoamine-oxidase inhibitor Iproniazid, was a drug used for the treatment of tuberculosis. In the current study we chronically treated DBA/2J mice for 2 weeks with paroxetine, a selective serotonin reuptake inhibitor, and collected fecal pellets as a proxy for the gut microbiota from the animals…

medicine.drug_classlcsh:RC435-571Serotonin reuptake inhibitorClinical SciencesmicrobiomeGut floraPharmacology03 medical and health sciences0302 clinical medicineRare Diseaseslcsh:PsychiatrymedicinePsychologyMicrobiomeCancerOriginal ResearchPsychiatrybile acidsantidepressantbiologyBile acidbusiness.industryDepressionbiology.organism_classificationmedicine.diseaseParoxetinemetabolomics030227 psychiatryColo-Rectal CancerPsychiatry and Mental healthMental HealthGood Health and Well Being5.1 PharmaceuticalsPublic Health and Health ServicesAntidepressantDevelopment of treatments and therapeutic interventionsbusinessDigestive DiseasesDysbiosis030217 neurology & neurosurgeryBehavioural despair testmedicine.drugparoxetineFrontiers in psychiatry
researchProduct

Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives.

2019

Background::There is an urgent need for a better understanding and management of obesity and obesity- associated diseases. It is known that obesity is associated with structural and functional changes in the microbiome.Methods::The purpose of this review is to present current evidence from animal and human studies, demonstrating the effects and the potential efficacy of microbiota modulation in improving obesity and associated metabolic dysfunctions.Results::This review discusses possible mechanisms linking gut microbiota dysbiosis and obesity, since there is a dual interaction between the two of them. Furthermore, comments on bariatric surgery, as a favourable model to understand the under…

medicine.medical_specialtyBariatric Surgery030209 endocrinology & metabolismGut floraManagement of obesity03 medical and health sciencesTherapeutic approach0302 clinical medicineDrug DiscoverymedicineAnimalsHumansMicrobiomeObesity030304 developmental biologyAdiposityPharmacologyInflammation0303 health sciencesbiologyHuman studiesbusiness.industryAnimalMicrobiotamedicine.diseasebiology.organism_classificationObesitySurgeryDysbiosiGastrointestinal MicrobiomeObesity-associated diseaseDysbiosisbusinessDysbiosisHumanCurrent pharmaceutical design
researchProduct